Dr. Mark Steven Rasnake, MD

Dr. Rasnake practices at NCH Baker Hospital in Naples, Florida, part of NCH Healthcare System.

Dr. Rasnake's NPI, 1962464644, was assigned on April 6, 2006. Dr. Rasnake graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1998. Dr. Rasnake holds Tennessee license 34449.

Dr. Rasnake's primary practice is NCH Baker Hospital, at 350 7th St N, Naples, FL 34102 in Collier County. The practice phone is (239) 624-5000.

Dr. Rasnake's primary practice is NCH Baker Hospital in Naples, Florida, part of NCH Healthcare System. Dr. Rasnake is also affiliated with The University of Tennessee Medical Center. The medical group on file is NCH Medical Group - Hospitalists. Dmand AI also links Dr. Rasnake to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rasnake practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Rasnake's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Rasnake is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Rasnake's licenses on file in 2 states: Tennessee and Florida.

Dmand AI lists hiv/aids, joint or bone infection, shingles and UTI among the conditions Dr. Rasnake treats.

CMS data shows 476 Medicare services from Dr. Rasnake across 8 procedure codes in 2024, for 171 Medicare patients. Medicare paid $35,494 for them.

CMS counts 171 Medicare patients who saw Dr. Rasnake in 2024. The largest group is 75 to 84, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rasnake's median patient age at 73, with 48% women.

In 2024, Dr. Rasnake wrote 206 Medicare Part D claims for 51 patients. 76% of them were for generic drugs. CMS names the drug for 75 of them, across 4 drugs with 11 or more claims each, at $136,397 in total drug cost. In 2023, CMS named 115 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Rasnake for performance year 2024, reported through an alternative payment model (APM). Dr. Rasnake accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Rasnake, published from 2007 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Military Personnel. Dr. Rasnake has published most often in South Med J. Dr. Rasnake's most frequent co-authors are Duane Russell Hospenthal, MD, PhD, Rebecca Witherell, MD and Mohammed Ahsan, MD.

CMS Open Payments shows 206 general payments to Dr. Rasnake from 35 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 72% of the total. Pfizer Inc. paid the most, $1,458.

Dr. Rasnake graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1998.

Dr. Rasnake is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.